DNA damage increases telomerase activity and mRNA expression of telomeric repeat binding factor 2 in gastric cancer cells

Han-Bing Ning,Ji-Chang Li,Zhi-Guo Liu,Dai-Ming Fan
DOI: https://doi.org/10.11569/wcjd.v14.i10.942
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the possible involvement of telomerase and telomeric repeat binding factors (TRF1 and TRF2) in chemotherapeutic agents-induced DNA damage responses in gastric cancer cells.METHODS: Gastric cancer cell line SGC7901 and MKN28 were treated with various con-centrations of etoposide for 3, 6, 12, 24 and 36 h. Telomerase activity was measured by real-time quantitative telomeric repeat amplification protocol (RTQ-TRAP) assay. The expression of human telomerase reverse transcriptase (hTERT) mRNA was detected by real time reverse tran-scription polymerase chain reaction (RT-PCR). The expression of TRF1 and TRF2 were detectedby Western blot and real time RT-PCR at protein and mRNA level, respectively.RESULTS: Telomerase activity and TRF2 mRNA expression were up-regulated at the early stage of drug treatment in both cell lines (P < 0.05). The expression of TRF1 mRNA was also increased, but it was not significant (P > 0.05). The increase of telomerase activity was independent on hTERT mRNA levels, and TRF2 was significantly increased both in protein and mRNA levels (P < 0.05). The up-regulation was in a drug dose-dependent manner.CONCLUSION: Telomerase activity and TRF2 expression is possibly involved in the responses of gastric cancer cells to DNA-damaging drugs.
What problem does this paper attempt to address?